世界の結核検査市場2017年ー2025年:検査タイプ別(胸部X線、培養ベース検査、IGRA、マントー反応検査(TST)、核酸検査(NAT)、Xpert検査、血清学的検査、塗抹顕微鏡検査)、エンドユーザー別

◆英語タイトル:Tuberculosis Testing Market (Test Type - Chest X-Ray, Culture Based Tests, IGRA, Mantoux Test (TST), Nucleic Acid Testing (NAT), Xpert Test, Serological Tests, and Smear Microscopy; End-User - Academics and Research, Hospitals Laboratories, Physician's Office Laboratories, and Reference Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025
◆商品コード:TMR21MC021
◆発行会社(リサーチ会社):Transparency Market Research
◆発行日:2020年11月9日
◆ページ数:197
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,795 ⇒換算¥660,630見積依頼/購入/質問フォーム
Site Licence(同一拠点内共有可)USD8,795 ⇒換算¥1,002,630見積依頼/購入/質問フォーム
Enterprisewide Licence(複数拠点内共有可)USD11,795 ⇒換算¥1,344,630見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Transparency Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Transparency Market Research社の本調査資料では、世界の結核検査市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、検査タイプ別(胸部X線、培養検査、インターフェロンガンマ遊離検査(IGRA)、マントー反応検査(TST)、核酸検査(NAT)、Xpert検査、血清学的検査、塗抹顕微鏡検査)分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況など、以下の構成でまとめております。
・序論
・仮設・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・結核検査の世界市場規模:検査タイプ別(胸部X線、培養検査、インターフェロンガンマ遊離検査(IGRA)、マントー反応検査(TST)、核酸検査(NAT)、Xpert検査、血清学的検査、塗抹顕微鏡検査)
・結核検査の世界市場規模:エンドユーザー別
・結核検査の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争分析
【レポートの概要】

Global Tuberculosis Testing Market – Scope of Report

TMR’s report on the global Tuberculosis Testing Market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global Tuberculosis Testing Market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global Tuberculosis Testing Market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global tuberculosis testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global tuberculosis testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global tuberculosis testing market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global tuberculosis testing market.

The report delves into the competitive landscape of the global tuberculosis testing market. Key players operating in the global Tuberculosis Testing Market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global Tuberculosis Testing Market that have been profiled in this report.

Key Questions Answered in Global Tuberculosis Testing Market Report

What is the scope of growth of product companies in the global tuberculosis testing market?
What will be the Y-o-Y growth of the global Tuberculosis Testing Market between 2019 and 2027?
What is the influence of changing trends in technologies on the global tuberculosis testing market?
Will North America continue to be the most profitable market for global tuberculosis testing providers?
Which factors are anticipated to hamper the growth of the global Tuberculosis Testing Market during the forecast period?
Which are the leading companies in the global tuberculosis testing market?
Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global Tuberculosis Testing Market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global Tuberculosis Testing Market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the Tuberculosis Testing Market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the Tuberculosis Testing Market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global Tuberculosis Testing Market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global Tuberculosis Testing Market more reliably and accurately.

Regional Segmentation of Tuberculosis Testing Market

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

【レポートの目次】

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global tuberculosis testing market
4. Market Overview
4.1. Introduction
4.1.1. Test Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Tuberculosis Testing Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Burden of TB Worldwide
5.2. Burden of MDR-TB Worldwide
5.3. Challenges of Traditional Testing/Diagnostic Methods
5.4. Mergers & Acquisitions
6. Global Tuberculosis Testing Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Tuberculosis Testing Market Value Forecast, by Test Type, 2017–2027
6.2.1. Chest X-Ray
6.2.2. Culture Based Tests
6.2.3. Interferon-Gamma Release Assays (IGRA)
6.2.4. Mantoux Test (TST)
6.2.5. Nucleic Acid Testing (NAT), Xpert test
6.2.6. Serological Tests
6.2.7. Smear Microscopy
6.2.8. Other Tests (ADA, etc.)
6.3. Global Tuberculosis Testing Market Attractiveness, by Test Type
7. Global Tuberculosis Testing Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Tuberculosis Testing Market Value Forecast, by End-user, 2017–2027
7.2.1. Hospitals Laboratories
7.2.2. Reference Laboratories
7.2.3. Physician’s Office Laboratories
7.2.4. Academics and Research
7.2.5. Others (Home Health Agencies, etc.)
7.3. Global Tuberculosis Testing Market Attractiveness, by End-user
8. Global Tuberculosis Testing Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Tuberculosis Testing Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. North America Tuberculosis Testing Market Attractiveness, by Region
9. North America Tuberculosis Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
9.2.1. Chest X-Ray
9.2.2. Culture Based Tests
9.2.3. Interferon-Gamma Release Assays (IGRA)
9.2.4. Mantoux Test (TST)
9.2.5. Nucleic Acid Testing (NAT), Xpert test
9.2.6. Serological Tests
9.2.7. Smear Microscopy
9.2.8. Other Tests (ADA, etc.)
9.3. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
9.3.1. Hospitals Laboratories
9.3.2. Reference Laboratories
9.3.3. Physician’s Office Laboratories
9.3.4. Academics and Research
9.3.5. Others (Home Health Agencies, etc.)
9.4. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Tuberculosis Testing Market Attractiveness Analysis
9.5.1. By Test Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Tuberculosis Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
10.2.1. Chest X-Ray
10.2.2. Culture Based Tests
10.2.3. Interferon-Gamma Release Assays (IGRA)
10.2.4. Mantoux Test (TST)
10.2.5. Nucleic Acid Testing (NAT), Xpert test
10.2.6. Serological Tests
10.2.7. Smear Microscopy
10.2.8. Other Tests (ADA, etc.)
10.3. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
10.3.1. Hospitals Laboratories
10.3.2. Reference Laboratories
10.3.3. Physician’s Office Laboratories
10.3.4. Academics and Research
10.3.5. Others (Home Health Agencies, etc.)
10.4. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Tuberculosis Testing Market Attractiveness Analysis
10.5.1. By Test Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Tuberculosis Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
11.2.1. Chest X-Ray
11.2.2. Culture Based Tests
11.2.3. Interferon-Gamma Release Assays (IGRA)
11.2.4. Mantoux Test (TST)
11.2.5. Nucleic Acid Testing (NAT), Xpert test
11.2.6. Serological Tests
11.2.7. Smear Microscopy
11.2.8. Other Tests (ADA, etc.)
11.3. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
11.3.1. Hospitals Laboratories
11.3.2. Reference Laboratories
11.3.3. Physician’s Office Laboratories
11.3.4. Academics and Research
11.3.5. Others (Home Health Agencies, etc.)
11.4. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Tuberculosis Testing Market Attractiveness Analysis
11.5.1. By Test Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Tuberculosis Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
12.2.1. Chest X-Ray
12.2.2. Culture Based Tests
12.2.3. Interferon-Gamma Release Assays (IGRA)
12.2.4. Mantoux Test (TST)
12.2.5. Nucleic Acid Testing (NAT), Xpert test
12.2.6. Serological Tests
12.2.7. Smear Microscopy
12.2.8. Other Tests (ADA, etc.)
12.3. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
12.3.1. Hospitals Laboratories
12.3.2. Reference Laboratories
12.3.3. Physician’s Office Laboratories
12.3.4. Academics and Research
12.3.5. Others (Home Health Agencies, etc.)
12.4. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America Latin America
12.5. Latin America Tuberculosis Testing Market Attractiveness Analysis
12.5.1. By Test Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Tuberculosis Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
13.2.1. Chest X-Ray
13.2.2. Culture Based Tests
13.2.3. Interferon-Gamma Release Assays (IGRA)
13.2.4. Mantoux Test (TST)
13.2.5. Nucleic Acid Testing (NAT), Xpert test
13.2.6. Serological Tests
13.2.7. Smear Microscopy
13.2.8. Other Tests (ADA, etc.)
13.3. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
13.3.1. Hospitals Laboratories
13.3.2. Reference Laboratories
13.3.3. Physician’s Office Laboratories
13.3.4. Academics and Research
13.3.5. Others (Home Health Agencies, etc.)
13.4. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Tuberculosis Testing Market Attractiveness Analysis
13.5.1. By Test Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by Tier and Size of companies)
14.2. Market Share / Position Analysis, by Company, 2018
14.3. Competitive Business Strategies
14.4. Company Profiles
14.4.1. Thermo Fisher Scientific, Inc.
14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.1.2. Growth Strategies
14.4.1.3. SWOT Analysis
14.4.2. Alere, Inc.
14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.2.2. Growth Strategies
14.4.2.3. SWOT Analysis
14.4.3. Becton, Dickinson and Company
14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.3.2. Growth Strategies
14.4.3.3. SWOT Analysis
14.4.4. F. Hoffmann-La Roche AG
14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.4.2. Growth Strategies
14.4.4.3. SWOT Analysis
14.4.5. LIONEX Diagnostics & Therapeutics GmbH.
14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.5.2. Growth Strategies
14.4.5.3. SWOT Analysis
14.4.6. Danaher Corporation
14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.6.2. Growth Strategies
14.4.6.3. SWOT Analysis
14.4.7. Creative Diagnostics
14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.7.2. Growth Strategies
14.4.7.3. SWOT Analysis
14.4.8. QIAGEN
14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.8.2. Growth Strategies
14.4.8.3. SWOT Analysis
14.4.9. Hain Lifescience GmbH.
14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.9.2. Growth Strategies
14.4.9.3. SWOT Analysis
14.4.10. Oxford Immunotec Ltd.
14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.10.2. Growth Strategies
14.4.10.3. SWOT Analysis
14.4.11. Hologic, Inc.
14.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.11.2. Growth Strategies
14.4.11.3. SWOT Analysis
14.4.12. Cepheid
14.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.12.2. Growth Strategies
14.4.12.3. SWOT Analysis
14.4.13. Akonni Biosystems, Inc.
14.4.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.13.2. Growth Strategies
14.4.13.3. SWOT Analysis
14.4.14. bioMerieux SA
14.4.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.14.2. Growth Strategies
14.4.14.3. SWOT Analysis
14.4.15. Epistem Ltd
14.4.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.15.2. Growth Strategies
14.4.15.3. SWOT Analysis

List of Table

Table 01:Top 10 High TB burden countries with estimated number of new TB cases globally

Table 02:Estimated number of MDR-TB among all notified TB cases in high burden countries (2018)

Table 03:TB R&D Funders by Rank in 2018

Table 04:Tuberculosis Diagnostics tests Pipeline

Table 05:Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

Table 06:Global Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 07:Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Region, 2017–2027

Table 08:North America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 09:North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by Test Type, 2017–2027

Table 10:North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2017–2027

Table 11:Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 12:Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

Table 13:Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2017–2027

Table 14:Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 15:Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

Table 16:Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017–2027

Table 17:Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 18:Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

Table 19:Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017–2027

Table 20:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 21:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

Table 22:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017–2027

List of Figure

Figure 01:Global Tuberculosis Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2018-2027

Figure 02:Market Value Share, by Test Type (2018)

Figure 03:Market Value Share, by End User (2018)

Figure 04:Market Value Share, by Region (2018)

Figure 05:Annual Global Plan Research Funding Targets versus 2015 Funding on Tuberculosis

Figure 06:Total TB R&D Funding, 2005–2015

Figure 07:Total TB R&D Funding by Funder Category, 2015

Figure 08:Total TB R&D Funding by Funder Category, 2005–2015 (Mn)

Figure 09:Global Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 10:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chest X-Ray, 2017–2027

Figure 11:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Culture Based Tests,

Figure 12:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by IGRA, 2017–2027

Figure 13:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Mantoux test (TST), 2017–2027

Figure 14:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Nucleic Acid Testing (NAT), Xpert test, 2017–2027

Figure 15:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Serological Tests,

Figure 16:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Smear Microscopy, 2017–2027

Figure 17:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Other Tests (ADA, etc.), 2017–2027

Figure 18:Global Tuberculosis Testing Market Attractiveness, by Test Type, 2017-2025

Figure 19:Global Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

Figure 20:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 21:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reference Laboratories, 2017–2027

Figure 22:Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician’s Office Laboratories, 2017–2027

Figure 23:Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academics and Research, 2017–2027

Figure 24:Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 25:Global Tuberculosis Testing Market Attractiveness, by End-User, 2017-2025

Figure 26:Global Tuberculosis Testing Market Revenue (US$ Bn) Forecast, 2017–2027

Figure 27:Global Tuberculosis Testing Market Value Share Analysis, by Region, 2018 and 2027

Figure 28:Global Tuberculosis Testing Market Attractiveness, by Region, 2017-2025

Figure 29:North America Tuberculosis Testing Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 30:North America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027

Figure 31:North America Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027

Figure 32:North America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 33:North America Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

Figure 34:North America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027

Figure 35:North America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027

Figure 36:Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, 2017–2027

Figure 37:Europe Market Attractiveness Analysis, by Country, 2018-2027

Figure 38:Europe Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027

Figure 39:Europe Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 40:Europe Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

Figure 41:Europe Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027

Figure 42:Europe Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027

Figure 43:Asia Pacific Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 44:Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027

Figure 45:Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027

Figure 46:Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 47:Asia Pacific Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

Figure 48:Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027

Figure 49:Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027

Figure 50:Latin America Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 51:Latin America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027

Figure 52:Latin America Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027

Figure 53:Latin America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 54:Latin America Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

Figure 55:Latin America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027

Figure 56:Latin America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027

Figure 57:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 58:Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027

Figure 59:Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027

Figure 60:Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 61:Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

Figure 62:Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027

Figure 63:Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027

Figure 64:Thermo Fisher Scientific, Inc.- Breakdown of Net Sales (% Share), by Business segments (2018)

Figure 65:Thermo Fisher Scientific, Inc.- Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 66:Alere, Inc.- Revenue Split, by Operating Segment, 2015

Figure 67:Alere, Inc. - Total Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2018

Figure 68:Becton, Dickinson and Company - Breakdown of Net Sales, by Region, 2018

Figure 69:Becton, Dickinson and Company- Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 70:F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Division), by Region, 2015

Figure 71:F. Hoffmann-La Roche AG- Revenue (US$ Bn) & Y-o-Y Growth (%), 2015–2018

Figure 72:Danaher Corporation - Breakdown of Revenue, by Region, 2018

Figure 73:Danaher Corporation - Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2018

Figure 74:QIAGEN- Breakdown of Net Sales, by Business Segment, 2018

Figure 75:QIAGEN- Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2018

Figure 76:Oxford Immunotec Ltd.- Breakdown of Net Sales, by region, 2015

Figure 77:Oxford Immunotec Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 78: Hologic, Inc. - Breakdown of Net Sales, by Country/Region, 2015

Figure 79:Hologic, Inc. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 80:Cepheid - Breakdown of Net Sales, by Country/Region, 2015

Figure 81:Cepheid - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 82:bioMerieux SA - Breakdown of Net Sales, by Country/Region, 2018

Figure 83:bioMerieux SA - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 84:Epistem Ltd. - Breakdown of Net Sales, by Country/Region, 2015

Figure 85:Epistem Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の結核検査市場2017年ー2025年:検査タイプ別(胸部X線、培養ベース検査、IGRA、マントー反応検査(TST)、核酸検査(NAT)、Xpert検査、血清学的検査、塗抹顕微鏡検査)、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆